Natco Pharma expects India, Brazil, Canada markets to be revenue drivers in FY20

10 Jun 2019 Evaluate

Natco Pharma is expecting India, Brazil and Canada markets to be its revenue drivers during the current financial year, recording growth of 30% to 40%. The company expects India business alone is likely to grow by about 15% to 20%.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

821.70 8.05 (0.99%)
28-Jan-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.15
Dr. Reddys Lab 1223.65
Cipla 1315.60
Zydus Lifesciences 889.65
Lupin 2132.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×